{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:11:11Z","timestamp":1791976271442,"version":"4.4.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T00:00:00Z","timestamp":1632700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this study is to evaluate utility of MRI in differentiation of uterine low-grade endometrial stromal sarcoma (LGESS) from rare leiomyoma variants. This multi-center retrospective study included consecutive 25 patients with uterine LGESS and 42 patients with rare leiomyoma variants who had pretreatment MRI. Two radiologists (R1\/R2) independently evaluated MRI features, which were analyzed statistically using Fisher\u2019s exact test or Student's <jats:italic>t<\/jats:italic>-test. Subsequently, using a five-point Likert scale, the two radiologists evaluated the diagnostic performance of a pre-defined MRI system using features reported as characteristics of LGESS in previous case series: uterine tumor with high signal intensity (SI) on diffusion-weighted images and with either worm-like nodular extension, intra-tumoral low SI bands, or low SI rim on T2-weighted images. Area under the receiver operating characteristic curve (AUC), sensitivity, and specificity of the two readers\u2019 Likert scales were analyzed. Intra-tumoral low SI bands (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001), cystic\/necrotic change (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.02), absence of speckled appearance (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001) on T2-weighted images, and a low apparent diffusion coefficient value (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.02) were significantly associated with LGESS. The pre-defined MRI system showed very good diagnostic performance: AUC 0.86\/0.89, sensitivity 0.95\/0.95, and specificity 0.67\/0.69 for R1\/R2. MRI can be useful to differentiate uterine LGESS from rare leiomyoma variants.<\/jats:p>","DOI":"10.1038\/s41598-021-98473-z","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T10:20:00Z","timestamp":1632738000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Differentiation of uterine low-grade endometrial stromal sarcoma from rare leiomyoma variants by magnetic resonance imaging"],"prefix":"10.1038","volume":"11","author":[{"given":"Yuki","family":"Himoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Kido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusaku","family":"Moribata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Kurata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriomi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuki","family":"Shitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiya","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeaki","family":"Umeoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Minamiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Mandai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,27]]},"reference":[{"key":"98473_CR1","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1159\/000494225","volume":"41","author":"FC Thiel","year":"2018","unstructured":"Thiel, F. C. & Halmen, S. Low-grade endometrial stromal sarcoma\u2014A review. Oncol. Res. Treat. 41, 687\u2013692. https:\/\/doi.org\/10.1159\/000494225 (2018).","journal-title":"Oncol. Res. Treat."},{"issue":"Suppl 2","key":"98473_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/ijgo.12613","volume":"143","author":"N Mbatani","year":"2018","unstructured":"Mbatani, N., Olawaiye, A. B. & Prat, J. Uterine sarcomas. Int. J. Gynaecol. Obstet. 143(Suppl 2), 51\u201358. https:\/\/doi.org\/10.1002\/ijgo.12613 (2018).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"98473_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0090-8258(03)00207-5","volume":"90","author":"F Amant","year":"2003","unstructured":"Amant, F. et al. The diagnostic problem of endometrial stromal sarcoma: Report on six cases. Gynecol. Oncol. 90, 37\u201343. https:\/\/doi.org\/10.1016\/s0090-8258(03)00207-5 (2003).","journal-title":"Gynecol. Oncol."},{"key":"98473_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ejogrb.2018.09.027","volume":"230","author":"Q Chen","year":"2018","unstructured":"Chen, Q., Shi, H., Lu, W. & Lu, B. Unexpected uterine sarcomas in 4478 patients with electric power morcellation for leiomyomas. Eur. J. Obstet. Gynecol. Reprod. Biol. 230, 85\u201389. https:\/\/doi.org\/10.1016\/j.ejogrb.2018.09.027 (2018).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"98473_CR5","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/S1470-2045(09)70226-8","volume":"10","author":"F Amant","year":"2009","unstructured":"Amant, F., Coosemans, A., Debiec-Rychter, M., Timmerman, D. & Vergote, I. Clinical management of uterine sarcomas. Lancet Oncol. 10, 1188\u20131198. https:\/\/doi.org\/10.1016\/S1470-2045(09)70226-8 (2009).","journal-title":"Lancet Oncol."},{"key":"98473_CR6","doi-asserted-by":"publisher","first-page":"3412","DOI":"10.1200\/JCO.19.00562","volume":"37","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Association between power morcellation and mortality in women with unexpected uterine cancer undergoing hysterectomy or myomectomy. J. Clin. Oncol. 37, 3412\u20133424. https:\/\/doi.org\/10.1200\/JCO.19.00562 (2019).","journal-title":"J. Clin. Oncol."},{"key":"98473_CR7","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1097\/AOG.0000000000001415","volume":"127","author":"MUS Baggish","year":"2016","unstructured":"Baggish, M. U. S. Food and drug administration\u2019s guidance regarding morcellation of leiomyomas: Well-intentioned, but is it harmful for women?. Obstet. Gynecol. 127, 965\u2013966. https:\/\/doi.org\/10.1097\/AOG.0000000000001415 (2016).","journal-title":"Obstet. Gynecol."},{"key":"98473_CR8","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1097\/IGC.0000000000000911","volume":"27","author":"MJ Halaska","year":"2017","unstructured":"Halaska, M. J. et al. European society of gynecological oncology statement on fibroid and uterine morcellation. Int. J. Gynecol. Cancer 27, 189\u2013192. https:\/\/doi.org\/10.1097\/IGC.0000000000000911 (2017).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"98473_CR9","doi-asserted-by":"publisher","unstructured":"Ueda, H. et al. Unusual appearances of uterine leiomyomas: MR imaging findings and their histopathologic backgrounds. Radiographics 19, S131\u2013S145. https:\/\/doi.org\/10.1148\/radiographics.19.suppl_1.g99oc04s131 (1999).","DOI":"10.1148\/radiographics.19.suppl_1.g99oc04s131"},{"key":"98473_CR10","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1007\/s00330-016-4623-9","volume":"27","author":"Y Lakhman","year":"2017","unstructured":"Lakhman, Y. et al. Differentiation of uterine leiomyosarcoma from atypical leiomyoma: Diagnostic accuracy of qualitative MR imaging features and feasibility of texture analysis. Eur. Radiol. 27, 2903\u20132915. https:\/\/doi.org\/10.1007\/s00330-016-4623-9 (2017).","journal-title":"Eur. Radiol."},{"key":"98473_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.2463\/mrms.2014-0023","volume":"14","author":"A Sumi","year":"2015","unstructured":"Sumi, A. et al. Assessment of MR imaging as a tool to differentiate between the major histological types of uterine sarcomas. Magnet. Resonan. Med. Sci. (MRMS) 14, 295\u2013304. https:\/\/doi.org\/10.2463\/mrms.2014-0023 (2015).","journal-title":"Magnet. Resonan. Med. Sci. (MRMS)"},{"key":"98473_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5152\/dir.2014.14053","volume":"21","author":"P Santos","year":"2015","unstructured":"Santos, P. & Cunha, T. M. Uterine sarcomas: Clinical presentation and MRI features. Diagn. Interv. Radiol. 21, 4\u20139. https:\/\/doi.org\/10.5152\/dir.2014.14053 (2015).","journal-title":"Diagn. Interv. Radiol."},{"key":"98473_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.diii.2019.07.007","volume":"100","author":"S Sun","year":"2019","unstructured":"Sun, S. et al. How to differentiate uterine leiomyosarcoma from leiomyoma with imaging. Diagn. Interv. Imaging 100, 619\u2013634. https:\/\/doi.org\/10.1016\/j.diii.2019.07.007 (2019).","journal-title":"Diagn. Interv. Imaging"},{"key":"98473_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s40644-019-0247-z","volume":"19","author":"YL Huang","year":"2019","unstructured":"Huang, Y. L. et al. Utility of diffusion-weighted and contrast-enhanced magnetic resonance imaging in diagnosing and differentiating between high- and low-grade uterine endometrial stromal sarcoma. Cancer Imaging 19, 63. https:\/\/doi.org\/10.1186\/s40644-019-0247-z (2019).","journal-title":"Cancer Imaging"},{"key":"98473_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s003300000541","volume":"11","author":"M Ueda","year":"2001","unstructured":"Ueda, M. et al. MR imaging findings of uterine endometrial stromal sarcoma: Differentiation from endometrial carcinoma. Eur. Radiol. 11, 28\u201333. https:\/\/doi.org\/10.1007\/s003300000541 (2001).","journal-title":"Eur. Radiol."},{"key":"98473_CR16","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2214\/ajr.173.3.10470920","volume":"173","author":"T Koyama","year":"1999","unstructured":"Koyama, T. et al. MR imaging of endometrial stromal sarcoma: Correlation with pathologic findings. AJR Am. J. Roentgenol. 173, 767\u2013772. https:\/\/doi.org\/10.2214\/ajr.173.3.10470920 (1999).","journal-title":"AJR Am. J. Roentgenol."},{"key":"98473_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/jmri.22126","volume":"31","author":"R Furukawa","year":"2010","unstructured":"Furukawa, R. et al. Endometrial stromal sarcoma located in the myometrium with a low-intensity rim on T2-weighted images: Report of three cases and literature review. J. Magnet. Resonan. Imaging (JMRI) 31, 975\u2013979. https:\/\/doi.org\/10.1002\/jmri.22126 (2010).","journal-title":"J. Magnet. Resonan. Imaging (JMRI)"},{"key":"98473_CR18","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1097\/IGC.0000000000001114","volume":"27","author":"HM Li","year":"2017","unstructured":"Li, H. M. et al. Endometrial stromal sarcoma of the uterus: Magnetic resonance imaging findings including apparent diffusion coefficient value and its correlation with Ki-67 expression. Int. J. Gynecol. Cancer 27, 1877\u20131887. https:\/\/doi.org\/10.1097\/IGC.0000000000001114 (2017).","journal-title":"Int. J. Gynecol. Cancer"},{"key":"98473_CR19","unstructured":"WHO Classification of Tumours of Female Reproductive Organs. 4th edn. Vol. 6 (World Health Organization Classification of Tumours, 2014)."},{"key":"98473_CR20","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2018.29.e26","volume":"29","author":"TH Kim","year":"2018","unstructured":"Kim, T. H., Kim, J. W., Kim, S. Y., Kim, S. H. & Cho, J. Y. What MRI features suspect malignant pure mesenchymal uterine tumors rather than uterine leiomyoma with cystic degeneration?. J. Gynecol. Oncol. 29, e26. https:\/\/doi.org\/10.3802\/jgo.2018.29.e26 (2018).","journal-title":"J. Gynecol. Oncol."},{"key":"98473_CR21","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1148\/radiol.2015150400","volume":"279","author":"A Gladwish","year":"2016","unstructured":"Gladwish, A. et al. Association of apparent diffusion coefficient with disease recurrence in patients with locally advanced cervical cancer treated with radical chemotherapy and radiation therapy. Radiology 279, 158\u2013166. https:\/\/doi.org\/10.1148\/radiol.2015150400 (2016).","journal-title":"Radiology"},{"key":"98473_CR22","unstructured":"McBride, G. A Proposal for Strength-of-Agreement Criteria for Lin. s. Concordance Correlation Coefficient. https:\/\/www.medcalc.org\/download\/pdf\/McBride2005.pdf (2005)."},{"key":"98473_CR23","first-page":"203","volume":"19","author":"AM Simundic","year":"2009","unstructured":"Simundic, A. M. Measures of diagnostic accuracy: Basic definitions. Ejifcc 19, 203\u2013211 (2009).","journal-title":"Ejifcc"},{"key":"98473_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh, M. L. Interrater reliability: The kappa statistic. Biochemia medica 22, 276\u2013282 (2012).","journal-title":"Biochemia medica"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98473-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98473-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98473-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:12:00Z","timestamp":1670083920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98473-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,27]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98473"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98473-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,27]]},"assertion":[{"value":"22 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All disclosures are outside the submitted work. Dr. Matsumura reports personal fees from Unaffiliated Director, Takara Bio Inc., grants and personal fees from Astrazeneca, outside the submitted work. All other authors have nothing to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19124"}}